Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

rezafungin

rezafungin
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Rezzayo POWDER FOR INJECTION, INTRAVENOUS 200 mg      
Comments:

Formulary, restricted to ID. Rezzayo can be used in the inpatient and outpatient settings to facilitate hospital discharge. Self-pay patients should qualify for patient assistance/dose replacement per manufacturer.

 

 

 

 

 

Reviewed: February 2025

 

Rezafungin (Rezzayo) Spotlight

Last updated: Mar. 21, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved